These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2562885)

  • 21. [What is the benefit of adjuvant therapy in breast cancer?].
    Sauer H
    Fortschr Med; 1992 Nov; 110(30):16-8, 20. PubMed ID: 1468737
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjuvant tamoxifen and chemotherapy prolongs life and increases disease-free survival of women with breast cancer.
    Oncology (Williston Park); 1992 Jan; 6(1):86. PubMed ID: 1531606
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjuvant hormonotherapy for breast cancer.
    Grem JL; Carbone PP
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):235-9. PubMed ID: 3519232
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions].
    Goldhirsch A; Neuenschwander H; Castiglione M; Senn HJ; Cavalli F
    Schweiz Med Wochenschr; 1990 Nov; 120(47):1771-83. PubMed ID: 2255883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.
    Lancet; 1987 Jul; 2(8552):171-5. PubMed ID: 2885637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy for node-negative breast cancer: a proactive view.
    Glick JH
    Important Adv Oncol; 1990; ():183-97. PubMed ID: 2182518
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant treatment of breast cancer.
    Akerley WL
    R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
    [No Abstract]   [Full Text] [Related]  

  • 28. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 29. Ovarian ablation as adjuvant therapy for early-stage breast cancer.
    Pritchard KI
    Cancer Treat Res; 1998; 94():158-80. PubMed ID: 9587687
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of adjuvant tamoxifen: the latest results from the Cancer Research Campaign Adjuvant Breast Trial. Cancer Research Campaign Breast Cancer Trials Group.
    Eur J Cancer; 1992; 28A(4-5):904-7. PubMed ID: 1524921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
    Henderson IC
    Important Adv Oncol; 1990; ():199-216. PubMed ID: 1691137
    [No Abstract]   [Full Text] [Related]  

  • 32. Tamoxifen in the treatment and chemoprevention of breast cancer.
    Boothe VA; Pommier RF; Vetto JT
    Cancer Pract; 1994; 2(5):335-42. PubMed ID: 7697071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adjuvant hormonal therapy in lymph node-negative breast carcinoma patients in the postmenopause].
    Kurz C; Scholten C; Zielinski C; Czerwenka K; Kubista E; Spona J; Sevelda P
    Dtsch Med Wochenschr; 1992 Dec; 117(51-52):1943-6. PubMed ID: 1478168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer].
    Hoeller U; Borgmann K; Feyer P; Souchon R;
    Strahlenther Onkol; 2007 Oct; 183(10):535-44. PubMed ID: 17896084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adjuvant treatments of breast cancer].
    Namer M
    Bull Cancer; 1994; 81(10 Suppl):2-4. PubMed ID: 7718949
    [No Abstract]   [Full Text] [Related]  

  • 37. Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question!
    Bentzen SM; Yarnold JR
    J Clin Oncol; 2005 Sep; 23(25):6266-7; author reply 6267. PubMed ID: 16135499
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.
    ; Cuzick J; Ambroisine L; Davidson N; Jakesz R; Kaufmann M; Regan M; Sainsbury R
    Lancet; 2007 May; 369(9574):1711-23. PubMed ID: 17512856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adjuvant for breast cancer chemo-endocrine therapy].
    Taguchi T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):453-67. PubMed ID: 9530350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen therapy in breast cancer control worldwide.
    Love RR; Koroltchouk V
    Bull World Health Organ; 1993; 71(6):795-803. PubMed ID: 8313498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.